Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02515487 · ClinicalTrials.gov registry record · NA
An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer Survivors
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02515487 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 11 participants.
The verdict
NCT02515487, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The main goal of this project is to identify and remediate the cognitive difficulties, including processing speed and attention deficits in individuals who have undergone chemotherapy treatment. Recent research has demonstrated objective cognitive deficits following chemotherapy and that it is not an emotional reaction to the cancer diagnosis as it was once considered. There are a large number of woman diagnosed and treated for breast cancer that experience chemotherapy induced cognitive deficits. Subjects who participate in the study will be evaluated for cognitive abilities prior to chemotherapy treatment and after completion of chemotherapy. Participants will then have the option to participate in the second phase of the study, which involves the use of a computer-based Brain Fitness Program for 12 weeks. This is followed by another cognitive evaluation.
Interventions
- OTHER Brain Fitness Program (BFP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-09 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02515487
The ClinicalTrials.gov registry entry for NCT02515487 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brain Fitness Program (BFP) is the first listed.
NCT02515487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02515487 about?
NCT02515487 is a clinical study titled "An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer Survivors". The main goal of this project is to identify and remediate the cognitive difficulties, including processing speed and attention deficits in individuals who have undergone chemotherapy treatment. Recent research has demonstrated objective cognitive deficits following chemotherapy and that it is not a...
What is the current status of trial NCT02515487?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2013-09. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02515487?
The interventions under investigation include: Brain Fitness Program (BFP) (OTHER).
Who is sponsoring clinical trial NCT02515487?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.